Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Excess catecholamine syndrome. Pathophysiology and therapy.

H Rupp1

  • 1Molecular Cardiology Laboratory, Philipps University of Marburg, Germany.

Annals of the New York Academy of Sciences
|July 23, 1999
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Ergot alkaloids: Quantitation and recognition challenges.

Mycotoxin research·2013
Same author

Intrapericardial procedures for cardiac regeneration by stem cells: need for minimal invasive access (AttachLifter) to the normal pericardial cavity.

Herz·2010
Same author

Strategies to mitigate diffuse phosphorus pollution during rewetting of fen peat soils.

Water science and technology : a journal of the International Association on Water Pollution Research·2010
Same author

Inverse shift in serum polyunsaturated and monounsaturated fatty acids is associated with adverse dilatation of the heart.

Heart (British Cardiac Society)·2009
Same author

A new method to assess ventricular wall stress in patients with heart failure and its relation to heart rate variability.

International journal of cardiology·2008
Same author

Clinical profile of eprosartan: a different angiotensin II receptor blocker.

Cardiovascular & hematological agents in medicinal chemistry·2008

Lifestyle factors like excess calorie intake and psychological stress significantly impact primary hypertension and non-insulin-dependent diabetes mellitus (NIDDM). These factors increase blood pressure, heart rate, and sympathetic activity, potentially worsening health outcomes.

Area of Science:

  • Cardiovascular Physiology
  • Metabolic Disorders
  • Stress Physiology

Background:

  • Lifestyle factors, including diet and stress, play a crucial role in the development of primary hypertension and non-insulin-dependent diabetes mellitus (NIDDM).
  • Understanding the molecular mechanisms underlying these lifestyle influences is essential for developing effective interventions.

Purpose of the Study:

  • To investigate the molecular events associated with excess calorie intake and psychological stress in relation to hypertension and NIDDM.
  • To characterize the physiological responses to these lifestyle challenges using radiotelemetry in a rat model.

Main Methods:

  • Radiotelemetry was employed to monitor physiological parameters in rats subjected to excess calorie intake and intermittent food pellet feeding (psychological stress).

Related Experiment Videos

  • Measurements included blood pressure, heart rate, motility, urinary catecholamines, and cardiac norepinephrine levels.
  • Calcium (Ca2+) uptake in the sarcoplasmic reticulum was assessed to evaluate cellular calcium handling.

    • Main Results:

    • Increased calorie intake led to elevated systolic and diastolic blood pressure and heart rate, independent of the circadian rhythm.
    • Excessive sympathetic activity was observed with unchanged motility.
    • Psychological stress induced by food pellet feeding increased urinary catecholamines and cardiac norepinephrine.
    • A depressed rate of Ca2+ uptake by the sarcoplasmic reticulum was noted, suggesting potential cellular Ca2+ overload.

    Conclusions:

    • Both excess calorie intake and psychological stress contribute to an 'excess catecholamine syndrome'.
    • These lifestyle factors exacerbate hypertension and insulin resistance, potentially through increased sympathetic outflow.
    • Targeting sympathetic nervous system activity, possibly via I1-receptor agonists, may be a viable therapeutic strategy.